UY32210A - IMPROVED ACTIVATION PROCESS FOR THE PREPARATION OF SOLUBLE-PROTEIN POLYACARIUM CONJUGATES AND THEIR PURIFICATION BY HYDROPHOBIC INTERACTION - Google Patents

IMPROVED ACTIVATION PROCESS FOR THE PREPARATION OF SOLUBLE-PROTEIN POLYACARIUM CONJUGATES AND THEIR PURIFICATION BY HYDROPHOBIC INTERACTION

Info

Publication number
UY32210A
UY32210A UY0001032210A UY32210A UY32210A UY 32210 A UY32210 A UY 32210A UY 0001032210 A UY0001032210 A UY 0001032210A UY 32210 A UY32210 A UY 32210A UY 32210 A UY32210 A UY 32210A
Authority
UY
Uruguay
Prior art keywords
polysaccharide
protein
hydrophobic interaction
purification
polyacarium
Prior art date
Application number
UY0001032210A
Other languages
Spanish (es)
Inventor
Fernando Ferreira Chiesa
Norma Suarez Olivera
Laura Franco Fraguas
Federico Sastre Charlo
Original Assignee
Fernando Ferreira Chiesa
Norma Suarez Olivera
Laura Franco Fraguas
Federico Sastre Charlo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fernando Ferreira Chiesa, Norma Suarez Olivera, Laura Franco Fraguas, Federico Sastre Charlo filed Critical Fernando Ferreira Chiesa
Priority to UY0001032210A priority Critical patent/UY32210A/en
Publication of UY32210A publication Critical patent/UY32210A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Los presentes inventores, describen una mejora en la técnica de activación del antígeno polisacarídico activado con el reactivo tetragluoroborato de 1-ciano-4-(dimetilamino) piridinio (CDAPBF4) previamente reportada (Lees et al., 1996) y un proceso de purificación del conjugado polisacárido-proteína obtenido por éste método directamente a partir de la mezcla de reacción obtenida por el mencionado proceso, en un solo paso mediante cromatografía de interacción hidrofóbica sobre geles de matrices hidroxipropiladas o hidroxialquiladas, que permite la obtención del conjugado polisacárido-proteína libre tanto de polisacárido como de proteína sin conjugar, simplificando el proceso general de obtención del producto y brindando un producto con mejores características para ser utilizado como inmunógenoThe present inventors describe an improvement in the technique of activation of the activated polysaccharide antigen with the 1-cyano-4- (dimethylamino) pyridinium tetragluoroborate reagent (CDAPBF4) previously reported (Lees et al., 1996) and a purification process of the polysaccharide-protein conjugate obtained by this method directly from the reaction mixture obtained by said process, in a single step by hydrophobic interaction chromatography on hydroxypropylated or hydroxyalkylated matrix gels, which allows obtaining the polysaccharide-free protein conjugate both of polysaccharide as an unconjugated protein, simplifying the general process of obtaining the product and providing a product with better characteristics to be used as an immunogen

UY0001032210A 2009-10-29 2009-10-29 IMPROVED ACTIVATION PROCESS FOR THE PREPARATION OF SOLUBLE-PROTEIN POLYACARIUM CONJUGATES AND THEIR PURIFICATION BY HYDROPHOBIC INTERACTION UY32210A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY0001032210A UY32210A (en) 2009-10-29 2009-10-29 IMPROVED ACTIVATION PROCESS FOR THE PREPARATION OF SOLUBLE-PROTEIN POLYACARIUM CONJUGATES AND THEIR PURIFICATION BY HYDROPHOBIC INTERACTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY0001032210A UY32210A (en) 2009-10-29 2009-10-29 IMPROVED ACTIVATION PROCESS FOR THE PREPARATION OF SOLUBLE-PROTEIN POLYACARIUM CONJUGATES AND THEIR PURIFICATION BY HYDROPHOBIC INTERACTION

Publications (1)

Publication Number Publication Date
UY32210A true UY32210A (en) 2010-01-29

Family

ID=43447871

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032210A UY32210A (en) 2009-10-29 2009-10-29 IMPROVED ACTIVATION PROCESS FOR THE PREPARATION OF SOLUBLE-PROTEIN POLYACARIUM CONJUGATES AND THEIR PURIFICATION BY HYDROPHOBIC INTERACTION

Country Status (1)

Country Link
UY (1) UY32210A (en)

Similar Documents

Publication Publication Date Title
CO6382140A2 (en) VACCINE COMPOSITIONS UNDERSTANDING A FACTOR LINK PROTEIN H MUTADA
BRPI0611872B8 (en) polymeric reagent, conjugate, method for preparing a conjugate and pharmaceutical composition
BR112015015031A2 (en) glycoconjugation process
AR115072A2 (en) HUMAN ANTIBODIES THAT JOIN LYMPHOCYTE ACTIVATION GEN 3 (LAG-3) AND USES OF THEM
ECSP13011139A (en) ANTIBODIES AGAINST 2 HUMAN ANGIOPOYETINE
AR069747A1 (en) ANTI-B7H4 MONOCLONAL ANTIBODY CONJUGATE - PHARMACO AND METHODS OF USE
NI200900022A (en) SPECIFIC ANTIBODY OF PRLR AND USES OF THE SAME
BR112012013975A2 (en) b7h6 binding monoclonal antibodies and uses thereof
ECSP088212A (en) PROCESS TO PREPARE ANTIBODY AND MAITANSINOID CONJUGATES
AR080868A1 (en) PSMA X CD3 SINGLE SPECIFIC ANTIBODY SPECIFIC CHAIN OF CROSSED SPECIES
ECSP12011995A (en) ANTI-HER3 ANTIBODIES AND USES OF THE SAME
BR112014006822A2 (en) cd27l antigen binding proteins
AR069903A1 (en) ANTIBODY CONJUGATE - ASSOCIATED MOLECULA DIRECTED TO THE PROTEIN TIROSINA QUINASA 7 (PTK 7), PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, NUCLEIC ACID, EXPRESSION FACTOR AND RELATED HUMAN CELL AND ITS USE TO PREPARE A MEDICATION
CY1115639T1 (en) SPECIAL RACE DEATH SUBSCRIPTIONS
PA8626201A1 (en) CALIQUEAMYCIN CONJUGATES
WO2011069104A3 (en) Multispecific antibodies, antibody analogs, compositions, and methods
EA200702577A1 (en) METHOD OF MAKING VACCINES
UA111341C2 (en) Conjugates of amatoxin with improved linkers
AR066476A1 (en) ANTI-MUC16 ANTIBODIES DESIGNED WITH CYSTEINE AND ANTIBODIES AND PHARMACOS CONJUGAODS
AR047062A1 (en) CONJUGATED CARRIERS OF BETA IMMUNOGENIC PEPTIDES AND METHODS FOR PRODUCERS
BRPI0519232A2 (en) saccharide conjugate vaccines
CO6480930A2 (en) COMPOSITIONS AND PROCEDURES TO PREPARE IMMUNOGENIC COMPOSITIONS OF CAPSULAR POLYACACRIDE CONJUGATE OF SEROTIPO 5 AND 8 OF STAPHYLOCOCCUS AUREUS.
BRPI0518302A2 (en) Imaging Method by rm
TR201900778T4 (en) Immunogenic composition.
GT200800173A (en) MEDICINES CONTAINING FLUOROQUINOLONES